Kailera
Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS5
PHASE 3 / 2-33
RECRUITING0
READOUTS ≤12 MONTHS2
| TRIAL | PHASE | STATUS | CONDITION | N | PRIMARY COMPLETION |
|---|---|---|---|---|---|
| Ribupatide NCT07458269 |
P2 | Active, not recruiting | Obesity | 264 | 2027-05 |
| KAI-7535 NCT07497880 |
P2 | Active, not recruiting | Obesity; Overweight | 306 | 2027-07-07 |
| KaiNETIC-1 NCT07284875 |
P3 | Active, not recruiting | Obesity; Overweight | 2530 | 2028-02 |
| KaiNETIC-3 NCT07284979 |
P3 | Active, not recruiting | Obesity | 1270 | 2028-03 |
| KaiNETIC-2 NCT07284901 |
P3 | Active, not recruiting | Obesity With Diabetes; Overweight With Diabetes | 1270 | 2028-03-27 |